ویراسلول

History:

Vira Cellule Company was launched in 2021 with the purpose of developing and producing cell/gene therapy products and tissue engineering. The company has defined its production and development program in three phases: a short-term phase (the first two years) including cell separation kits; a medium-term phase (the first three years) including the development of tissue products and vials for injection containing growth factors secreted from cells (products globally known as cell-free therapy for topical use in dermatology (hair loss and rejuvenation) and orthopedics (osteoarthritis)); and a long-term phase (the first five years) in the field of cell therapy for neurological diseases (MS and stroke) and oncology (GvHD and colon and breast cancers).

Vision:

Innovating novel solutions in the field of regenerative medicine to restore patients’ lives

Mission:

To become the most valuable company in Iran in the field of regenerative medicine for patients, customers, colleagues, investors, and business partners